BRUNETTI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 760
EU - Europa 482
AS - Asia 242
Totale 1.484
Nazione #
US - Stati Uniti d'America 757
IT - Italia 199
IE - Irlanda 161
CN - Cina 76
HK - Hong Kong 76
VN - Vietnam 75
RU - Federazione Russa 27
UA - Ucraina 22
FI - Finlandia 15
SE - Svezia 15
DE - Germania 13
CH - Svizzera 8
SG - Singapore 8
BE - Belgio 5
AT - Austria 4
FR - Francia 4
GB - Regno Unito 3
NL - Olanda 3
IL - Israele 2
UZ - Uzbekistan 2
BG - Bulgaria 1
CA - Canada 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
JP - Giappone 1
LB - Libano 1
MX - Messico 1
RO - Romania 1
TR - Turchia 1
Totale 1.484
Città #
Chandler 208
Dublin 161
Perugia 102
San Mateo 85
Hong Kong 76
Dong Ket 75
Wilmington 38
Medford 35
Princeton 33
Altamura 31
Beijing 30
Lawrence 30
Andover 24
Falls Church 16
Redwood City 16
Los Angeles 12
Redmond 12
Rome 11
Saint Petersburg 11
Ann Arbor 10
Norwalk 10
Des Moines 9
Singapore 8
Helsinki 7
San Paolo di Civitate 6
Brussels 5
Chicago 4
Jacksonville 4
Torino 4
Boardman 3
Cambridge 3
Frankfurt Am Main 3
Basel 2
Campobasso 2
Collazzone 2
Houston 2
Lausanne 2
Nanjing 2
Nepi 2
Northvale 2
Sant'ilario D'enza 2
Shanghai 2
Tappahannock 2
Todi 2
Zhengzhou 2
Acireale 1
Amsterdam 1
Arezzo 1
Ashburn 1
Belgioioso 1
Dearborn 1
Evanston 1
Foligno 1
Gatchina 1
Groningen 1
Guatemala City 1
Izmir 1
Lappeenranta 1
Mainz 1
Mexico City 1
Milan 1
Mississauga 1
Modesto 1
Nanning 1
Omsk 1
Paris 1
Perm 1
Pitesti 1
Ponzano Veneto 1
San Diego 1
St Petersburg 1
Tampa 1
Tokyo 1
Tong 1
Umbertide 1
Vienna 1
Totale 1.139
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 100
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 84
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 75
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 62
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 62
Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia 61
Mutant NPM1 Maintains the Leukemic State through HOX Expression 60
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 56
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 54
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 53
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 52
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 49
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 47
How I diagnose and treat NPM1-mutated AML 45
DNMT3A in Leukemia 44
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 43
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 42
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 41
NPM1-mutated acute myeloid leukemia: from bench to bedside 40
CD123 (IL-3R alpha) IS CONSISTENTLY EXPRESSED ON ACUTE MYELOID LEUKEMIA (AML) CARRYING NUCLEOPHOSMIN (NPM1) GENE MUTATION 38
TFEB regulates murine liver cell fate during development and regeneration 36
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 35
Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice. 33
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 31
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 30
Effect of the COVID-19 Pandemic on Laboratory and Clinical Research: A Testimony and a Call to Action From Researchers 30
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 30
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 26
New insights into the biology of acute myeloid leukemia with mutated NPM1 26
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 23
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 23
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 22
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 21
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 21
CD123 Is Consistently Expressed on NPM1-Mutated AML Cells 20
Current status and future perspectives in targeted therapy of NPM1-mutated AML 19
null 18
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 13
Overlapping features of therapy-related and de novoNPM1-mutated AML 13
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 6
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 6
NPM1-mutated AML with starry sky pattern 4
Totale 1.594
Categoria #
all - tutte 6.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/202074 1 0 2 0 5 1 1 7 16 36 5 0
2020/2021241 0 3 11 7 79 12 5 31 13 4 1 75
2021/2022383 5 77 1 6 20 16 7 77 12 45 62 55
2022/2023622 36 107 10 57 54 67 1 30 216 11 26 7
2023/2024222 12 31 11 8 1 8 66 2 17 23 43 0
Totale 1.594